We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
[Fe III Cl(TMPPH 2)][Fe III Cl 4 ] 2 : A Stand-Alone Molecular Nanomedicine That Induces High Cytotoxicity by Ferroptosis.
- Authors
Wang, Xiao; Feng, Jia-Hao; Zeng, Chun-Mei; Zhang, Ze-Sheng; Cao, Feng-Lin; Zhang, Wen-Hua; Chen, Jin-Xiang; Young, David J.
- Abstract
Developing clinically meaningful nanomedicines for cancer therapy requires the drugs to be effective, safe, simple, cheap, and easy to store. In the present work, we report that a simple cationic Fe(III)-rich salt of [FeIIICl(TMPPH2)][FeIIICl4]2 (Fe-TMPP) exhibits a superior anticancer performance on a broad spectrum of cancer cell lines, including breast, colorectal cancer, liver, pancreatic, prostate, and gastric cancers, with half maximal inhibitory concentration (IC50) values in the range of 0.098–3.97 μM (0.066–2.68 μg mL−1), comparable to the best-reported medicines. Fe-TMPP can form stand-alone nanoparticles in water without the need for extra surface modification or organic-solvent-assisted antisolvent precipitation. Critically, Fe-TMPP is TME-responsive (TME = tumor microenvironment), and can only elicit its function in the TME with overexpressed H2O2, converting H2O2 to the cytotoxic •OH to oxidize the phospholipid of the cancer cell membrane, causing ferroptosis, a programmed cell death process of cancer cells.
- Subjects
BREAST; CYTOTOXINS; NANOMEDICINE; APOPTOSIS; DRUG efficacy; CANCER cells
- Publication
Molecules, 2024, Vol 29, Issue 11, p2495
- ISSN
1420-3049
- Publication type
Article
- DOI
10.3390/molecules29112495